BPA Call 75H71122A00161-75H71224F28038
- Not listed
- This is a federal contract award from the Department of Health and Human Services' Indian Health Service (IHS) to McKesson Corporation, a healthcare services and information technology company. The contract is a Blanket Purchase Agreement (BPA) call valued at $249,000.00 with a completion date of August 12, 2025. Under this firm fixed price contract, McKesson will provide pharmaceutical products such as penicillin injections and alvimopan capsules to IHS service units nationwide. McKesson also...
- The Department of Health and Human Services' Indian Health Service awarded a firm fixed price blanket purchase agreement (BPA) call to Mckesson Corporation, a healthcare services and information technology company, to provide pharmaceutical products such as penicillin injections and alvimopan capsules. The $249,000.00 contract has a completion date of May 4, 2024 and does not utilize any set-aside designations. This award is part of a larger $675 million, seven-year National Supply Service...
- This federal contract award was issued by the Department of Health and Human Services' Indian Health Service (IHS) to Mckesson Corporation, a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and related distribution services to federal government customers. The contract, valued at $189,432.03, is a firm fixed price delivery order for the provision of pharmaceutical products such as penicillin injections and alvimopan capsules to the IHS....
- This federal contract award is for a blanket purchase agreement (BPA) call to provide pharmaceutical supplies to the Indian Health Service (IHS), a division of the Department of Health and Human Services. The BPA call has a ceiling value of $250,000.00 and runs from August 24, 2024 to August 23, 2025. The contract was awarded to Mckesson Corporation, a healthcare services and information technology company, to deliver pharmaceutical products such as penicillin injections and alvimopan...
- This federal contract award is an indefinite-delivery order in the amount of $87,921.40 issued by the Defense Logistics Agency (DLA) to Mckesson Corporation, a healthcare services and IT company, to provide pharmaceutical products such as penicillin injections and alvimopan capsules. The order is part of a broader Blanket Purchase Agreement (BPA) Mckesson holds with the Indian Health Service (IHS), valued at up to $710 million over seven years, to provide pharmaceutical supplies not available...
- This is a $15,000 firm fixed-price blanket purchase agreement (BPA) call awarded by the Indian Health Service, a civilian agency within the Department of Health and Human Services, to Mckesson Corporation (doing business as Mckesson Drug Company). Mckesson, a for-profit healthcare services and IT company, is providing pharmaceutical products such as penicillin injections and alvimopan capsules to support federal health programs and facilities. The contract is part of a larger $675 million,...
- This is a federal contract award to Mckesson Corporation, a healthcare services and information technology company, by the Department of Health and Human Services' Indian Health Service (IHS). The contract is a $290,871.39 firm fixed price delivery order under the IHS National Supply Service Center prime vendor blanket purchase agreement, which has an estimated value of $675 million over seven years. The contract is to provide pharmaceutical products such as penicillin injections and alvimopan...
- This is a firm fixed price contract awarded by the Department of Health and Human Services' Indian Health Service (IHS) to Mckesson Corporation, a healthcare services and information technology company. The contract, with a potential value of $126,000.00, is a Blanket Purchase Agreement (BPA) call order for open market pharmaceutical products to support the IHS. No set-aside was used. Mckesson, the prime contractor, has a history of providing pharmaceutical products and services to various...
- This federal contract award is a delivery order awarded by the Department of Health and Human Services' (HHS) Indian Health Service (IHS) to Mckesson Corporation, doing business as Mckesson Drug Company, a healthcare services and information technology company. The $198,381.31 firm-fixed-price contract is for the delivery of pharmaceutical products such as penicillin injections and alvimopan capsules to IHS service units and military treatment facilities. Mckesson has a $675 million multi-year...
- This is a federal contract award to Mckesson Corporation, a for-profit healthcare services and IT company, by the Department of Health and Human Services' Indian Health Service (IHS) and the Department of Veterans Affairs' Veterans Health Administration (VA). The contract, valued at $807,185.06, is a firm fixed price delivery order for pharmaceutical products such as penicillin injections and alvimopan capsules. Mckesson also holds a $675 million National Supply Service Center prime vendor...
- 75H71122A00161Blanket Purchase Agreement
- 75H71122A00161-75H71224F28038BPA Call
This federal contract award is a Blanket Purchase Agreement (BPA) call placed by the Department of Health and Human Services' Indian Health Service (IHS) with Mckesson Corporation, registered as Mckesson Drug Company. The contract, valued at $249,000, is for the delivery of pharmaceutical products such as penicillin injections and alvimopan capsules to support IHS healthcare facilities and services. Mckesson, a for-profit healthcare services and IT company, has served as a prime contractor for various federal agencies, including the Department of Veterans Affairs and the Defense Logistics Agency, providing pharmaceutical products and distribution services. This BPA call is part of a larger $710 million, seven-year BPA between Mckesson and IHS to furnish pharmaceutical supplies not available through the VA's pharmacy prime vendor program. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $249.0k | 5/17/24 |